L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice

Walif Aji, Stefano Ravalli, Matthias Szabolcs, Xian Cheng Jiang, Robert R. Sciacca, Robert E. Michler, Paul J. Cannon

Research output: Contribution to journalArticle

140 Citations (Scopus)

Abstract

Background: The potential antiatherosclerotic actions of NO were investigated in four groups of mice (n=10 per group) lacking functional LDL receptor genes, an animal model of familial hypercholesterolemia. Group 1 was fed a regular chow diet. Groups 2 through 4 were fed a 1.25% high-cholesterol diet. In addition, group 3 received supplemental L-arginine and group 4 received L-arginine and N(ω)-nitro-L-arginine (L-NA), an inhibitor of NO synthase (NOS). Methods and Results: Animals were killed at 6 months; aortas were stained with oil red O for planimetry and with antibodies against constitutive and inducible NOSs. Plasma cholesterol was markedly increased in the animals receiving the high-cholesterol diet. Xanthomas appeared in all mice fed the high-cholesterol diet alone but not in those receiving L- arginine. Aortic atherosclerosis was present in all mice on the high- cholesterol diet. The mean atherosclerotic lesion area was reduced significantly (P<.01) in the cholesterol-fed mice given L-arginine compared with those receiving the high-cholesterol diet alone. The mean atherosclerotic lesion area was significantly larger (P<.01) in cholesterol- fed mice receiving L-arginine + L-NA than in those on the high-cholesterol diet alone. Within the atherosclerotic plaques, endothelial cells immunoreacted for endothelial cell NOS; macrophages, foam cells, and smooth muscle cells immunostained strongly for inducible NOS and nitrotyrosine residues. Conclusions: The data indicate that L-arginine prevents xanthoma formation and reduces atherosclerosis in LDL receptor knockout mice fed a high-cholesterol diet. The abrogation of the beneficial effects of L- arginine by L-NA suggests that the anti-atherosclerotic actions of L-arginine are mediated by NOS. The data suggest that L-arginine may be beneficial in familial hypercholesterolemia.

Original languageEnglish (US)
Pages (from-to)430-437
Number of pages8
JournalCirculation
Volume95
Issue number2
StatePublished - 1997
Externally publishedYes

Fingerprint

Xanthomatosis
LDL Receptors
Knockout Mice
Arginine
Atherosclerosis
Cholesterol
Diet
Nitric Oxide Synthase
Hyperlipoproteinemia Type II
Endothelial Cells
Foam Cells
Atherosclerotic Plaques
Action Potentials
Smooth Muscle Myocytes
Aorta
Animal Models
Macrophages

Keywords

  • atherosclerosis
  • genes
  • hypercholesterolemia
  • L-arginine
  • nitric oxide synthase

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Aji, W., Ravalli, S., Szabolcs, M., Jiang, X. C., Sciacca, R. R., Michler, R. E., & Cannon, P. J. (1997). L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice. Circulation, 95(2), 430-437.

L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice. / Aji, Walif; Ravalli, Stefano; Szabolcs, Matthias; Jiang, Xian Cheng; Sciacca, Robert R.; Michler, Robert E.; Cannon, Paul J.

In: Circulation, Vol. 95, No. 2, 1997, p. 430-437.

Research output: Contribution to journalArticle

Aji, W, Ravalli, S, Szabolcs, M, Jiang, XC, Sciacca, RR, Michler, RE & Cannon, PJ 1997, 'L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice', Circulation, vol. 95, no. 2, pp. 430-437.
Aji, Walif ; Ravalli, Stefano ; Szabolcs, Matthias ; Jiang, Xian Cheng ; Sciacca, Robert R. ; Michler, Robert E. ; Cannon, Paul J. / L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice. In: Circulation. 1997 ; Vol. 95, No. 2. pp. 430-437.
@article{a7567671fcf941f4962211fd4f74cb7d,
title = "L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice",
abstract = "Background: The potential antiatherosclerotic actions of NO were investigated in four groups of mice (n=10 per group) lacking functional LDL receptor genes, an animal model of familial hypercholesterolemia. Group 1 was fed a regular chow diet. Groups 2 through 4 were fed a 1.25{\%} high-cholesterol diet. In addition, group 3 received supplemental L-arginine and group 4 received L-arginine and N(ω)-nitro-L-arginine (L-NA), an inhibitor of NO synthase (NOS). Methods and Results: Animals were killed at 6 months; aortas were stained with oil red O for planimetry and with antibodies against constitutive and inducible NOSs. Plasma cholesterol was markedly increased in the animals receiving the high-cholesterol diet. Xanthomas appeared in all mice fed the high-cholesterol diet alone but not in those receiving L- arginine. Aortic atherosclerosis was present in all mice on the high- cholesterol diet. The mean atherosclerotic lesion area was reduced significantly (P<.01) in the cholesterol-fed mice given L-arginine compared with those receiving the high-cholesterol diet alone. The mean atherosclerotic lesion area was significantly larger (P<.01) in cholesterol- fed mice receiving L-arginine + L-NA than in those on the high-cholesterol diet alone. Within the atherosclerotic plaques, endothelial cells immunoreacted for endothelial cell NOS; macrophages, foam cells, and smooth muscle cells immunostained strongly for inducible NOS and nitrotyrosine residues. Conclusions: The data indicate that L-arginine prevents xanthoma formation and reduces atherosclerosis in LDL receptor knockout mice fed a high-cholesterol diet. The abrogation of the beneficial effects of L- arginine by L-NA suggests that the anti-atherosclerotic actions of L-arginine are mediated by NOS. The data suggest that L-arginine may be beneficial in familial hypercholesterolemia.",
keywords = "atherosclerosis, genes, hypercholesterolemia, L-arginine, nitric oxide synthase",
author = "Walif Aji and Stefano Ravalli and Matthias Szabolcs and Jiang, {Xian Cheng} and Sciacca, {Robert R.} and Michler, {Robert E.} and Cannon, {Paul J.}",
year = "1997",
language = "English (US)",
volume = "95",
pages = "430--437",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice

AU - Aji, Walif

AU - Ravalli, Stefano

AU - Szabolcs, Matthias

AU - Jiang, Xian Cheng

AU - Sciacca, Robert R.

AU - Michler, Robert E.

AU - Cannon, Paul J.

PY - 1997

Y1 - 1997

N2 - Background: The potential antiatherosclerotic actions of NO were investigated in four groups of mice (n=10 per group) lacking functional LDL receptor genes, an animal model of familial hypercholesterolemia. Group 1 was fed a regular chow diet. Groups 2 through 4 were fed a 1.25% high-cholesterol diet. In addition, group 3 received supplemental L-arginine and group 4 received L-arginine and N(ω)-nitro-L-arginine (L-NA), an inhibitor of NO synthase (NOS). Methods and Results: Animals were killed at 6 months; aortas were stained with oil red O for planimetry and with antibodies against constitutive and inducible NOSs. Plasma cholesterol was markedly increased in the animals receiving the high-cholesterol diet. Xanthomas appeared in all mice fed the high-cholesterol diet alone but not in those receiving L- arginine. Aortic atherosclerosis was present in all mice on the high- cholesterol diet. The mean atherosclerotic lesion area was reduced significantly (P<.01) in the cholesterol-fed mice given L-arginine compared with those receiving the high-cholesterol diet alone. The mean atherosclerotic lesion area was significantly larger (P<.01) in cholesterol- fed mice receiving L-arginine + L-NA than in those on the high-cholesterol diet alone. Within the atherosclerotic plaques, endothelial cells immunoreacted for endothelial cell NOS; macrophages, foam cells, and smooth muscle cells immunostained strongly for inducible NOS and nitrotyrosine residues. Conclusions: The data indicate that L-arginine prevents xanthoma formation and reduces atherosclerosis in LDL receptor knockout mice fed a high-cholesterol diet. The abrogation of the beneficial effects of L- arginine by L-NA suggests that the anti-atherosclerotic actions of L-arginine are mediated by NOS. The data suggest that L-arginine may be beneficial in familial hypercholesterolemia.

AB - Background: The potential antiatherosclerotic actions of NO were investigated in four groups of mice (n=10 per group) lacking functional LDL receptor genes, an animal model of familial hypercholesterolemia. Group 1 was fed a regular chow diet. Groups 2 through 4 were fed a 1.25% high-cholesterol diet. In addition, group 3 received supplemental L-arginine and group 4 received L-arginine and N(ω)-nitro-L-arginine (L-NA), an inhibitor of NO synthase (NOS). Methods and Results: Animals were killed at 6 months; aortas were stained with oil red O for planimetry and with antibodies against constitutive and inducible NOSs. Plasma cholesterol was markedly increased in the animals receiving the high-cholesterol diet. Xanthomas appeared in all mice fed the high-cholesterol diet alone but not in those receiving L- arginine. Aortic atherosclerosis was present in all mice on the high- cholesterol diet. The mean atherosclerotic lesion area was reduced significantly (P<.01) in the cholesterol-fed mice given L-arginine compared with those receiving the high-cholesterol diet alone. The mean atherosclerotic lesion area was significantly larger (P<.01) in cholesterol- fed mice receiving L-arginine + L-NA than in those on the high-cholesterol diet alone. Within the atherosclerotic plaques, endothelial cells immunoreacted for endothelial cell NOS; macrophages, foam cells, and smooth muscle cells immunostained strongly for inducible NOS and nitrotyrosine residues. Conclusions: The data indicate that L-arginine prevents xanthoma formation and reduces atherosclerosis in LDL receptor knockout mice fed a high-cholesterol diet. The abrogation of the beneficial effects of L- arginine by L-NA suggests that the anti-atherosclerotic actions of L-arginine are mediated by NOS. The data suggest that L-arginine may be beneficial in familial hypercholesterolemia.

KW - atherosclerosis

KW - genes

KW - hypercholesterolemia

KW - L-arginine

KW - nitric oxide synthase

UR - http://www.scopus.com/inward/record.url?scp=0031023733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031023733&partnerID=8YFLogxK

M3 - Article

VL - 95

SP - 430

EP - 437

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 2

ER -